Related Experiment Video
Updated: Aug 23, 2026

Quantification of Cerebral Vascular Architecture using Two-photon Microscopy in a Mouse Model of HIV-induced Neuroinflammation
Published on: January 12, 2016
Cardio- and cerebrovascular events in HIV-infected persons
A d'Arminio1, C A Sabin, A N Phillips
1Università degli Studi di Milano, Italy.
Insights
Combination antiretroviral treatment (CART) significantly increases the risk of cardiovascular and cerebrovascular disease events (CCVE) in HIV patients. This risk elevation is comparable to the known impact of CART on myocardial infarction (MI).
Area of Science:
- Cardiology
- HIV Medicine
- Epidemiology
Background:
- Previous D:A:D Study data showed a 26% annual increase in myocardial infarction (MI) risk with combination antiretroviral treatment (CART).
- The D:A:D Study is a large, international collaboration tracking HIV-infected patients.
Purpose of the Study:
- To investigate if the risk of other cardio- and cerebro-vascular disease events (CCVE) is similarly increased by CART.
- To assess the overall cardiovascular risk associated with CART in HIV patients.
Main Methods:
- Prospective follow-up of 23,468 HIV-infected patients across 11 cohorts in Europe, USA, and Australia.
- Defined CCVE as the first occurrence of acute MI, invasive cardiovascular procedures, stroke, or cardiovascular death.
- Utilized Poisson regression models adjusted for known CCVE risk factors.
Main Results:
- Over 36,145 person-years, 207 patients experienced a CCVE (23.7% fatal).
- The incidence of first CCVE was 5.7 per 1000 person-years.
- Each year of CART exposure increased CCVE risk by 26% (RR, 1.26; 95% CI, 1.14-1.38).
Conclusions:
- Combination antiretroviral treatment (CART) demonstrably increases the risk of cardiovascular and cerebrovascular diseases (CCVD).
- The risk increase for CCVD is comparable to that observed for myocardial infarction (MI).
- Findings support the hypothesis that atherosclerosis may be a side-effect of CART.
Objective:
Recent results from the D:A:D Study indicated that the incidence of myocardial infarction (MI) increased by 26% per year of exposure to combination antiretroviral treatment (CART). The present study was performed to investigate whether this risk was similar when including other cardio- and cerebro-vascular disease events (CCVE).
Design:
D:A:D is an international collaboration of 11 cohorts, following 23 468 HIV-infected patients prospectively at 188 clinics in 21 countries situated in Europe, USA and Australia.
Methods:
The end-point was the occurrence of a first CCVE during prospective follow-up, defined as the first of: acute MI, invasive cardiovascular procedures, stroke, or death from other cardiovascular disease. Relative rates (RR) for CCVE from Poisson regression models and 95% confidence intervals (CI) are reported. All models are adjusted for other risk factors for CCVE, including age, gender, ethnicity, family history, body mass index, and smoking status as well as cohort and HIV transmission group.
Results:
Over 36 145 person-years of follow-up, 207 patients experienced at least one CCVE (23.7% fatal). The first event was MI in 126 patients, invasive cardiovascular procedure in 39 patients, stroke in 38 patients, and death from other cardiovascular disease in four patients. The incidence of first CCVE was 5.7 per 1000 person-years [95% confidence interval (CI) 5.0-6.5] and increased with longer exposure to CART (RR per year of exposure, 1.26; 95% CI, 1.14-1.38; P < 0.0001).
Conclusion:
CART increases the risk of CCVD, and this increase is comparable with how CART affects the risk of MI. This finding is consistent with the hypothesis that atherosclerosis is a side-effect of CART.
Related Concept Videos
Cryptococcal Meningitis
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease IV: Preventive Measures
Cardiovascular Drugs: Classification based on Therapeutic Indications
Hemorrhagic Stroke ll: Pathophysiology
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...